脑部放疗,上午比下午敏感许多!
- Y1 M( P% D4 P7 x+ r
0 r( _$ Q/ C8 Y% z& v: Z6 p& ~: x8 s5 `) z4 ^+ v0 N3 u7 U2 h
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
) ?2 A( \% k2 ?- ]0 k+ HGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
0 Z/ C, f) p- a5 X: gRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
( H4 N, J2 `( G& l$ @" x, _SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.% S& o$ I0 Z. M* c- n* `
) `# [0 c0 d9 E1 L8 t5 ?4 e8 Y
Abstract
2 J' r1 X. Z8 h* LBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time. U& N$ ?( u. k5 H' k7 ~1 ^1 h
' }. b6 K8 ?$ E- O4 GMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
# K3 X' j6 q3 ?( q- I
2 _% m( \! m0 D3 w4 y. TRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
' ?& O" D* I5 A% B" K, a7 h$ M1 a1 j0 B- o. I! a7 i
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.5 V1 A4 M; ]5 F a4 ?' T
+ D+ x) z2 C* k- T5 Q0 R& ?3 J |